Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
114
Views
11
CrossRef citations to date
0
Altmetric
Original Research

c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients

Shu-Hui Lin1 Department of Surgical Pathology, Changhua Christian Hospital, Changhua, Taiwan;2 Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, Taichung, Taiwan
,
Hsin-Kai Wang3 Public Health Bureau, Tainan City Government, Tainan, Taiwan;4 Department of Medical Technology, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli, Taiwan
,
Kun-Tu Yeh1 Department of Surgical Pathology, Changhua Christian Hospital, Changhua, Taiwan;5 School of Medicine, Chung Shan Medical University, Taichung, Taiwan
,
Hui-Chun Tai1 Department of Surgical Pathology, Changhua Christian Hospital, Changhua, Taiwan;6 Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan
,
Hui-Yi Wang1 Department of Surgical Pathology, Changhua Christian Hospital, Changhua, Taiwan
,
Lan-Ru Huang2 Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, Taichung, Taiwan
,
Chun-Wen Chiu7 Department of Emergency Medicine, Changhua Christian Hospital, Changhua, Taiwan
,
Chia-Min Chung8 Graduate Institute of BioMedical Sciences, China Medical University, Taichung, Taiwan;9 Environment-Omics-Diseases Research Center, China Medical University Hospital, Taichung, Taiwan
&
Bharath Kumar Velmurugan10 Toxicology and Biomedicine Research Group, Faculty of Applied Sciences, Ton Duc Thang University, Ho Chi Minh City, VietnamCorrespondence[email protected]
 show all
Pages 5163-5169 | Published online: 05 Jun 2019

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29. doi:10.3322/caac.2125425559415
  • Kumar M, Nanavati R, Modi TG, Dobariya C. Oral cancer: etiology and risk factors: a review. J Cancer Res Ther. 2016;12(2):458–463. doi:10.4103/0973-1482.18669627461593
  • Neville BW, Day TA. Oral cancer and precancerous lesions. Ca-Cancer J Clin. 2002;52(4):195–215.12139232
  • Pai R, Pai S, Lalitha R, et al. Over-expression of c-Myc oncoprotein in oral squamous cell carcinoma in the South Indian population. Ecancermedicalscience. 2009;3:128. doi:10.3332/ecancer.2009.12822275997
  • Field JK, Spandidos DA, Stell PM, Vaughan ED, Evan GI, Moore JP. Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene. 1989;4(12):1463–1468.2687767
  • Riou GF. Proto-oncogenes and prognosis in early carcinoma of the uterine cervix. Cancer Surv. 1988;7(3):441–456.2853996
  • Spandidos DA, Yiagnisis M, Papadimitriou K, Field JK. ras, c-myc and c-erbB-2 oncoproteins in human breast cancer. Anticancer Res. 1989;9(5):1385–1393.2574023
  • Varley JM, Swallow JE, Brammar WJ, Whittaker JL, Walker RA. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis. Oncogene. 1987;1(4):423–430.3330785
  • Adams JM, Kelly PN, Dakic A, Carotta S, Nutt SL, Strasser A. Role of “cancer stem cells” and cell survival in tumor development and maintenance. Cold Spring Harb Symp Quant Biol. 2008;73:451–459. doi:10.1101/sqb.2008.73.00419022754
  • Eilers M, Eisenman RN. Myc’s broad reach. Genes Dev. 2008;22(20):2755–2766. doi:10.1101/gad.171240818923074
  • Nair SK, Burley SK. Structural aspects of interactions within the Myc/Max/Mad network. Curr Top Microbiol Immunol. 2006;302:123–143.16620027
  • Nakagawa M, Takizawa N, Narita M, Ichisaka T, Yamanaka S. Promotion of direct reprogramming by transformation-deficient Myc. P Natl Acad Sci USA. 2010;107(32):14152–14157. doi:10.1073/pnas.1009374107
  • Eversole LR, Sapp JP. c-myc oncoprotein expression in oral precancerous and early cancerous lesions. Eur J Cancer B Oral Oncol. 1993;29B(2):131–135.8180589
  • Sakai H, Kawano K, Okamura K, Hashimoto N. Immunohistochemical localization of c-myc oncogene product and EGF receptor in oral squamous-cell carcinoma. J Oral Pathol Med. 1990;19(1):1–4.2179534
  • Perez-Sayans M, Suarez-Penaranda JM, Padin-Iruegas E, et al. Quantitative determination of c-myc facilitates the assessment of prognosis of OSCC patients. Oncol Rep. 2014;31(4):1677–1682. doi:10.3892/or.2014.304024573767
  • Zeng W, Sun H, Meng F, et al. Nuclear C-MYC expression level is associated with disease progression and potentially predictive of two year overall survival in prostate cancer. Int J Clin Exp Pathol. 2015;8(2):1878–1888.25973080
  • Elster D, Jaenicke LA, Eilers M, von Eyss B. TEAD activity is restrained by MYC and stratifies human breast cancer subtypes. Cell Cycle (Georgetown, Tex). 2016;15(19):2551–2556. doi:10.1080/15384101.2016.1207837
  • Lee KS, Kwak Y, Nam KH, et al. Favorable prognosis in colorectal cancer patients with co-expression of c-MYC and ss-catenin. BMC Cancer. 2016;16(1):730. doi:10.1186/s12885-016-2770-727619912
  • Chen YJ, Lin SC, Kao T, et al. Genome-wide profiling of oral squamous cell carcinoma. J Pathol. 2004;204(3):326–332. doi:10.1002/path.164015372456
  • Gong Y, Zhang X, Chen R, Wei Y, Zou Z, Chen X. Cytoplasmic expression of C-MYC protein is associated with risk stratification of mantle cell lymphoma. PeerJ. 2017;5:e3457–e3457. doi:10.7717/peerj.345728626618
  • Bockelman C, Koskensalo S, Hagstrom J, Lundin M, Ristimaki A, Haglund C. CIP2A overexpression is associated with c-Myc expression in colorectal cancer. Cancer Biol Ther. 2012;13(5):289–295. doi:10.4161/cbt.1892222310977
  • Trivedi TI, Tankshali RA, Goswami JV, Shukla SN, Shah PM, Shah NG. Identification of site-specific prognostic biomarkers in patients with oral squamous cell carcinoma. Neoplasma. 2011;58(3):217–226.21391738
  • Vora HH, Shah NG, Patel DD, Trivedi TI, Chikhlikar PR. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis. J Surg Oncol. 2003;82(1):34–50. doi:10.1002/jso.1018312501167
  • Cui J, Dong BW, Liang P, Yu XL, Yu DJ. Effect of c-myc, Ki-67, MMP-2 and VEGF expression on prognosis of hepatocellular carcinoma patients undergoing tumor resection. World J Gastroenterol. 2004;10(10):1533–1536. doi:10.3748/wjg.v10.i10.153315133868
  • Shah NG, Trivedi TI, Tankshali RA, et al. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis. Head Neck-J Sci Spec. 2009;31(12):1544–1556. doi:10.1002/hed.21126

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.